Specializing in developing medical devices to reduce blood stream infections, Novonate Inc's lead effort and device particularity involve umbilical cord catheters. These devices involve insertion into newborn babies to provide life-saving nutrients and medications directly into their bloodstream. Annually in the US, more than 200,000 babies require umbilical cord catheters to receive nutrients and medicine. Typically, umbilical catheters are held in place with tape and adhesive - a method that increases the risk of complications and infections. The LifeBubble umbilical catheter securement system developed by Novoate offers a safer, innovative, and user-friendly method that allows for easy positioning and removal while protecting the insertion site. In February 2023 it was announced that the diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie) had acquired Novonate, Inc - and its LifeBubble technology - a device that revolutionizes umbilical catheter protection and securement to improve safety for neonates in the intensive care setting.
